Multicenter, Double-blind, Placebo-controlled Randomized Trial to Evaluate the Efficacy and Safety of Intravenous Administration of Intermittent Doses of Levosimendan in Ambulatory Patients With Advanced CHF: the LION-HEART Study
Phase of Trial: Phase IV
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms LION HEART
- 13 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Oct 2015 Planned End Date changed from 1 Jun 2014 to 1 Nov 2015 as reported by ClinicalTrials.gov record.
- 20 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.